Cao HL, Dong WX, Xu MQ, Zhang YJ, Wang SN, Piao MY, Cao XC, Wang BM. Clinical features of upper gastrointestinal serrated lesions: An endoscopy database analysis of 98746 patients. World J Gastroenterol 2016; 22(45): 10038-10044 [PMID: 28018111 DOI: 10.3748/wjg.v22.i45.10038]
Corresponding Author of This Article
Dr. Bang-Mao Wang, Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Disease, Heping District 154 Anshan Road, Tianjin 300052, China. tjmughgi@hotmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Dec 7, 2016; 22(45): 10038-10044 Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10038
Table 1 General information on patients with serrated lesions in upper gastrointestinal tract
n (%)
Total
21
Mean age (yr), mean ± SD
55.3 ± 17.2
Gender, male
11 (52.4)
Body mass index (kg/m2), mean ± SD
24.9 ± 5.8
18.5-23.9
13 (61.9)
≥ 24.0
8 (38.1)
History of smoking
7 (33.3)
Alcohol consumption
10 (47.6)
Family history of gastric cancer
1 (4.8)
Indications for endoscopy
Upper abdominal pain
5 (23.8)
Nausea, vomit and reflux
4 (19.0)
Anemia and edema
4 (19.0)
Positive fecal occult blood test
3 (14.3)
A history of gastric polyps
3 (14.3)
Dyspepsia
2 (9.5)
Table 2 Clinical features of serrated lesions in upper gastrointestinal tract
n (%)
Size (mm), mean ± SD
11.7 ± 10.3
≤ 5
8 (38.1)
5-10
4 (19.0)
10-20
6 (28.6)
20-30
1 (4.8)
≥ 30
2 (9.5)
Distribution
Esophagus
1 (4.8)
Cardia
3 (14.3)
Corpus
9 (42.9)
Antrum
5 (23.8)
Duodenum
3 (14.3)
Morphology
Serrated hyperplasia
6 (28.6)
Hyperplastic polyps
8 (38.1)
Adenoma
6 (28.6)
Adenocarcinoma
1 (4.8)
Situation of serrated lesions in mucosal lesions
Inflammation or ulcer
3 (14.3)
Serrated polyps
14 (66.7)
Ménétrier gastropathy
3 (14.3)
Duodenal cancer
1 (4.8)
Colonoscopy findings
18
No-polyp
4 (22.2)
Hyperplastic polyps
7 (38.9)
Non-advanced adenomas
3 (16.7)
Advanced adenomas
4 (22.2)
Tubular adenoma with high grade dysplasia
1 (5.6)
Tubulovillous adenoma
2 (11.1)
Adenoma > 10 mm
1 (5.6)
Table 3 Colonoscopy findings in the patients with serrated lesions in upper gastrointestinal tract
Serrated lesions in upper gastrointestinal tract mucosal lesions (n)
Colonoscopy findings (n)
Inflammation or ulcer (3)
HPs (1)
HPs (8)
AA (2), NAA (1), HPs (2)
Serrated adenoma (6)
AA (2), NAA (2), HPs (2)
Ménétrier gastropathy (3)
HPs (2)
Duodenal cancer (1)
Absent
Table 4 Prevalence of colorectal adenoma in patients with serrated lesions in upper gastrointestinal tract and the control group n (%)
Patients with serrated lesions in UPGI(n = 18)
Average group(n = 72)
OR (95%CI)
P value
Colorectal adenoma
7 (38.9)
8 (11.1)
5.091 (1.534-16.890)
0.010
Non-advanced adenoma
3 (16.7)
5 (6.9)
2.680 (0.576-12.463)
0.195
Advanced adenoma
4 (22.2)
3 (4.2)
6.571 (1.322-32.660)
0.028
Citation: Cao HL, Dong WX, Xu MQ, Zhang YJ, Wang SN, Piao MY, Cao XC, Wang BM. Clinical features of upper gastrointestinal serrated lesions: An endoscopy database analysis of 98746 patients. World J Gastroenterol 2016; 22(45): 10038-10044